These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36741845)

  • 21. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).
    Smilowitz NR; Mahajan AM; Roe MT; Hellkamp AS; Chiswell K; Gulati M; Reynolds HR
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):e003443. PubMed ID: 29246884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure.
    Broch K; Andreassen AK; Ueland T; Michelsen AE; Stueflotten W; Aukrust P; Aakhus S; Gullestad L
    Int J Cardiol; 2015 Jan; 179():378-84. PubMed ID: 25464491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Lelonek M
    Kardiol Pol; 2014; 72(8):725-34. PubMed ID: 24846354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of soluble ST2 in adults with congenital heart disease.
    Geenen LW; Baggen VJM; van den Bosch AE; Eindhoven JA; Cuypers JAAE; Witsenburg M; Boersma E; Roos-Hesselink JW
    Heart; 2019 Jul; 105(13):999-1006. PubMed ID: 30700520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
    Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA
    Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
    Aimo A; Januzzi JL; Vergaro G; Richards AM; Lam CSP; Latini R; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Passino C; Emdin M
    Eur J Heart Fail; 2020 Nov; 22(11):2078-2088. PubMed ID: 31919929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome.
    Demyanets S; Speidl WS; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Krychtiuk KA; Wonnerth A; Weiss TW; Huber K; Wojta J
    PLoS One; 2014; 9(4):e95055. PubMed ID: 24751794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of ST2 biomarker for the evaluation of myocardial remodeling in patients with ischemic heart failure with preserved ejection fraction].
    Kop'eva KV; Teplyakov AT; Grakova EV; Soldatenko MV; Ogurkova ON; Ahmedov SD
    Kardiologiia; 2018 SOct; (S10):33-43. PubMed ID: 30362427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis.
    Willems S; Quax PH; de Borst GJ; de Vries JP; Moll FL; de Kleijn DP; Hoefer IE; Pasterkamp G
    Atherosclerosis; 2013 Nov; 231(1):48-53. PubMed ID: 24125409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
    PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the level of serum soluble ST2 and invasively measured aortic pulse pressure in patients undergoing coronary angiography.
    Kim HL; Lee JP; Lim WH; Seo JB; Zo JH; Kim MA; Kim SH
    Medicine (Baltimore); 2019 Feb; 98(8):e14215. PubMed ID: 30813128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Snider J; Cohn JN
    Circ Heart Fail; 2014 May; 7(3):418-26. PubMed ID: 24622243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress.
    Zhang HF; Xie SL; Chen YX; Mai JT; Wang JF; Zhu WL; Zhu LG
    J Transl Med; 2012 Jun; 10():120. PubMed ID: 22682001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
    Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ
    J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
    Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
    Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
    Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Sun YC; Liu PY; Ko YL
    Atherosclerosis; 2017 Feb; 257():71-77. PubMed ID: 28110258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Levels of Hcy, sST2 and CA-125 in CHF Patients and Their Correlation with Cardiac Function Classification.
    Ma W; Zhang P; Hu H
    Heart Surg Forum; 2023 Sep; 26(5):E449-E454. PubMed ID: 37920091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of β-Blocker Therapy on the Level of Soluble ST2 Protein in Pediatric Dilated Cardiomyopathy.
    Jiao M; Wang X; Liang Y; Yang Y; Gu Y; Wang Z; Lv Z; Jin M
    Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.